+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Wound Debridement Market 2023-2027

  • PDF Icon

    Report

  • 131 Pages
  • July 2023
  • Region: Global
  • TechNavio
  • ID: 5868391
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The wound debridement market is forecasted to grow by USD 474.77 million during 2022-2027, accelerating at a CAGR of 7.31% during the forecast period. The report on the wound debridement market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by technological advancements in wound debridement products, increasing prevalence of acute and chronic wounds, and increasing volume of surgical procedures.

The wound debridement market is segmented as below:

By End-user

  • Hospitals
  • Clinics
  • Others

By Product

  • Autolytic
  • Surgical
  • Mechanical
  • Enzymatic
  • Others

By Geographical Landscape

  • North America
  • Europe
  • Asia
  • Rest of World (ROW)
This study identifies the increasing use of telemedicine in wound debridement treatments as one of the prime reasons driving the wound debridement market growth during the next few years. Also, expanding indications of wound debridement devices and emergence of nanoparticles like copper, silver, gold titanium, and zinc oxide to treat wounds will lead to sizable demand in the market.

The report on the wound debridement market covers the following areas:

  • Wound debridement market sizing
  • Wound debridement market forecast
  • Wound debridement market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading wound debridement market vendors that include Arobella Medical LLC, B.Braun SE, BioMonde Ltd., Bioventus LLC, Brightwake Ltd., Coloplast AS, ConvaTec Group Plc, DeRoyal Industries Inc., EZ Debride, Integra Lifesciences Corp., Labomar S.p.A, Lohmann and Rauscher GmbH and Co. KG, Medaxis AG, Mediwound Ltd., Medline Industries LP, Molnlycke Health Care AB, Pulsecare Medical LLC, RLS Global AB, Smith and Nephew plc, and Zimmer Biomet Holdings Inc. Also, the wound debridement market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

1 Executive Summary
1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by End-user
Exhibit 06: Executive Summary - Chart on Market Segmentation by Product
Exhibit 07: Executive Summary - Chart on Incremental Growth
Exhibit 08: Executive Summary - Data Table on Incremental Growth
Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
2 Market Landscape
2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics
3 Market Sizing
3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2022
3.4 Market outlook: Forecast for 2022-2027
Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
4 Historic Market Size
4.1 Global wound debridement market 2017 - 2021
Exhibit 18: Historic Market Size - Data Table on global wound debridement market 2017 - 2021 ($ million)
4.2 End-user Segment Analysis 2017 - 2021
Exhibit 19: Historic Market Size - End-user Segment 2017 - 2021 ($ million)
4.3 Product Segment Analysis 2017 - 2021
Exhibit 20: Historic Market Size - Product Segment 2017 - 2021 ($ million)
4.4 Geography Segment Analysis 2017 - 2021
Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
4.5 Country Segment Analysis 2017 - 2021
Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
5 Five Forces Analysis
5.1 Five forces summary
Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
5.2 Bargaining power of buyers
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
5.3 Bargaining power of suppliers
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
5.4 Threat of new entrants
Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
5.5 Threat of substitutes
Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
5.6 Threat of rivalry
Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
5.7 Market condition
Exhibit 29: Chart on Market condition - Five forces 2022 and 2027
6 Market Segmentation by End-user
6.1 Market segments
Exhibit 30: Chart on End-user - Market share 2022-2027 (%)
Exhibit 31: Data Table on End-user - Market share 2022-2027 (%)
6.2 Comparison by End-user
Exhibit 32: Chart on Comparison by End-user
Exhibit 33: Data Table on Comparison by End-user
6.3 Hospitals - Market size and forecast 2022-2027
Exhibit 34: Chart on Hospitals - Market size and forecast 2022-2027 ($ million)
Exhibit 35: Data Table on Hospitals - Market size and forecast 2022-2027 ($ million)
Exhibit 36: Chart on Hospitals - Year-over-year growth 2022-2027 (%)
Exhibit 37: Data Table on Hospitals - Year-over-year growth 2022-2027 (%)
6.4 Clinics - Market size and forecast 2022-2027
Exhibit 38: Chart on Clinics - Market size and forecast 2022-2027 ($ million)
Exhibit 39: Data Table on Clinics - Market size and forecast 2022-2027 ($ million)
Exhibit 40: Chart on Clinics - Year-over-year growth 2022-2027 (%)
Exhibit 41: Data Table on Clinics - Year-over-year growth 2022-2027 (%)
6.5 Others - Market size and forecast 2022-2027
Exhibit 42: Chart on Others - Market size and forecast 2022-2027 ($ million)
Exhibit 43: Data Table on Others - Market size and forecast 2022-2027 ($ million)
Exhibit 44: Chart on Others - Year-over-year growth 2022-2027 (%)
Exhibit 45: Data Table on Others - Year-over-year growth 2022-2027 (%)
6.6 Market opportunity by End-user
Exhibit 46: Market opportunity by End-user ($ million)
Exhibit 47: Data Table on Market opportunity by End-user ($ million)
7 Market Segmentation by Product
7.1 Market segments
Exhibit 48: Chart on Product - Market share 2022-2027 (%)
Exhibit 49: Data Table on Product - Market share 2022-2027 (%)
7.2 Comparison by Product
Exhibit 50: Chart on Comparison by Product
Exhibit 51: Data Table on Comparison by Product
7.3 Autolytic - Market size and forecast 2022-2027
Exhibit 52: Chart on Autolytic - Market size and forecast 2022-2027 ($ million)
Exhibit 53: Data Table on Autolytic - Market size and forecast 2022-2027 ($ million)
Exhibit 54: Chart on Autolytic - Year-over-year growth 2022-2027 (%)
Exhibit 55: Data Table on Autolytic - Year-over-year growth 2022-2027 (%)
7.4 Surgical - Market size and forecast 2022-2027
Exhibit 56: Chart on Surgical - Market size and forecast 2022-2027 ($ million)
Exhibit 57: Data Table on Surgical - Market size and forecast 2022-2027 ($ million)
Exhibit 58: Chart on Surgical - Year-over-year growth 2022-2027 (%)
Exhibit 59: Data Table on Surgical - Year-over-year growth 2022-2027 (%)
7.5 Mechanical - Market size and forecast 2022-2027
Exhibit 60: Chart on Mechanical - Market size and forecast 2022-2027 ($ million)
Exhibit 61: Data Table on Mechanical - Market size and forecast 2022-2027 ($ million)
Exhibit 62: Chart on Mechanical - Year-over-year growth 2022-2027 (%)
Exhibit 63: Data Table on Mechanical - Year-over-year growth 2022-2027 (%)
7.6 Enzymatic - Market size and forecast 2022-2027
Exhibit 64: Chart on Enzymatic - Market size and forecast 2022-2027 ($ million)
Exhibit 65: Data Table on Enzymatic - Market size and forecast 2022-2027 ($ million)
Exhibit 66: Chart on Enzymatic - Year-over-year growth 2022-2027 (%)
Exhibit 67: Data Table on Enzymatic - Year-over-year growth 2022-2027 (%)
7.7 Others - Market size and forecast 2022-2027
Exhibit 68: Chart on Others - Market size and forecast 2022-2027 ($ million)
Exhibit 69: Data Table on Others - Market size and forecast 2022-2027 ($ million)
Exhibit 70: Chart on Others - Year-over-year growth 2022-2027 (%)
Exhibit 71: Data Table on Others - Year-over-year growth 2022-2027 (%)
7.8 Market opportunity by Product
Exhibit 72: Market opportunity by Product ($ million)
Exhibit 73: Data Table on Market opportunity by Product ($ million)
8 Customer Landscape
8.1 Customer landscape overview
Exhibit 74: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Drivers, Challenges, and Trends
9.1 Market drivers
9.2 Market challenges
9.3 Impact of drivers and challenges
Exhibit 75: Impact of drivers and challenges in 2022 and 2027
9.4 Market trends
10 Vendor Landscape
10.1 Overview
10.2 Vendor landscape
Exhibit 76: Overview on Criticality of inputs and Factors of differentiation
10.3 Landscape disruption
Exhibit 77: Overview on factors of disruption
10.4 Industry risks
Exhibit 78: Impact of key risks on business
11 Vendor Analysis
11.1 Vendors covered
Exhibit 79: Vendors covered
11.2 Market positioning of vendors
Exhibit 80: Matrix on vendor position and classification
11.3 Arobella Medical LLC
Exhibit 81: Arobella Medical LLC - Overview
Exhibit 82: Arobella Medical LLC - Product/Service
Exhibit 83: Arobella Medical LLC - Key offerings
11.4 B.Braun SE
Exhibit 84: B.Braun SE - Overview
Exhibit 85: B.Braun SE - Business segments
Exhibit 86: B.Braun SE - Key news
Exhibit 87: B.Braun SE - Key offerings
Exhibit 88: B.Braun SE - Segment focus
11.5 Bioventus LLC
Exhibit 89: Bioventus LLC - Overview
Exhibit 90: Bioventus LLC - Business segments
Exhibit 91: Bioventus LLC - Key news
Exhibit 92: Bioventus LLC - Key offerings
Exhibit 93: Bioventus LLC - Segment focus
11.6 Coloplast AS
Exhibit 94: Coloplast AS - Overview
Exhibit 95: Coloplast AS - Business segments
Exhibit 96: Coloplast AS - Key news
Exhibit 97: Coloplast AS - Key offerings
Exhibit 98: Coloplast AS - Segment focus
11.7 ConvaTec Group Plc
Exhibit 99: ConvaTec Group Plc - Overview
Exhibit 100: ConvaTec Group Plc - Product/Service
Exhibit 101: ConvaTec Group Plc - Key news
Exhibit 102: ConvaTec Group Plc - Key offerings
11.8 Integra Lifesciences Corp.
Exhibit 103: Integra Lifesciences Corp. - Overview
Exhibit 104: Integra Lifesciences Corp. - Business segments
Exhibit 105: Integra Lifesciences Corp. - Key news
Exhibit 106: Integra Lifesciences Corp. - Key offerings
Exhibit 107: Integra Lifesciences Corp. - Segment focus
11.9 Labomar S.p.A
Exhibit 108: Labomar S.p.A - Overview
Exhibit 109: Labomar S.p.A - Product/Service
Exhibit 110: Labomar S.p.A - Key offerings
11.10 Lohmann and Rauscher GmbH and Co. KG
Exhibit 111: Lohmann and Rauscher GmbH and Co. KG - Overview
Exhibit 112: Lohmann and Rauscher GmbH and Co. KG - Product/Service
Exhibit 113: Lohmann and Rauscher GmbH and Co. KG - Key offerings
11.11 Medaxis AG
Exhibit 114: Medaxis AG - Overview
Exhibit 115: Medaxis AG - Product/Service
Exhibit 116: Medaxis AG - Key offerings
11.12 Mediwound Ltd.
Exhibit 117: Mediwound Ltd. - Overview
Exhibit 118: Mediwound Ltd. - Product/Service
Exhibit 119: Mediwound Ltd. - Key offerings
11.13 Medline Industries LP
Exhibit 120: Medline Industries LP - Overview
Exhibit 121: Medline Industries LP - Product/Service
Exhibit 122: Medline Industries LP - Key offerings
11.14 Molnlycke Health Care AB
Exhibit 123: Molnlycke Health Care AB - Overview
Exhibit 124: Molnlycke Health Care AB - Product/Service
Exhibit 125: Molnlycke Health Care AB - Key offerings
11.15 Pulsecare Medical LLC
Exhibit 126: Pulsecare Medical LLC - Overview
Exhibit 127: Pulsecare Medical LLC - Product/Service
Exhibit 128: Pulsecare Medical LLC - Key offerings
11.16 Smith and Nephew plc
Exhibit 129: Smith and Nephew plc - Overview
Exhibit 130: Smith and Nephew plc - Business segments
Exhibit 131: Smith and Nephew plc - Key news
Exhibit 132: Smith and Nephew plc - Key offerings
Exhibit 133: Smith and Nephew plc - Segment focus
11.17 Zimmer Biomet Holdings Inc.
Exhibit 134: Zimmer Biomet Holdings Inc. - Overview
Exhibit 135: Zimmer Biomet Holdings Inc. - Business segments
Exhibit 136: Zimmer Biomet Holdings Inc. - Key news
Exhibit 137: Zimmer Biomet Holdings Inc. - Key offerings
Exhibit 138: Zimmer Biomet Holdings Inc. - Segment focus
12 Appendix
12.1 Scope of the report
12.2 Inclusions and exclusions checklist
Exhibit 139: Inclusions checklist
Exhibit 140: Exclusions checklist
12.3 Currency conversion rates for US$
Exhibit 141: Currency conversion rates for US$
12.4 Research methodology
Exhibit 142: Research methodology
Exhibit 143: Validation techniques employed for market sizing
Exhibit 144: Information sources
12.5 List of abbreviations
Exhibit 145: List of abbreviations
List of Exhibits
Exhibits 1: Executive Summary - Chart on Market Overview
Exhibits 2: Executive Summary - Data Table on Market Overview
Exhibits 3: Executive Summary - Chart on Global Market Characteristics
Exhibits 4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits 5: Executive Summary - Chart on Market Segmentation by End-user
Exhibits 6: Executive Summary - Chart on Market Segmentation by Product
Exhibits 7: Executive Summary - Chart on Incremental Growth
Exhibits 8: Executive Summary - Data Table on Incremental Growth
Exhibits 9: Executive Summary - Chart on Vendor Market Positioning
Exhibits 10: Parent market
Exhibits 11: Market Characteristics
Exhibits 12: Offerings of vendors included in the market definition
Exhibits 13: Market segments
Exhibits 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibits 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibits 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits 18: Historic Market Size - Data Table on global wound debridement market 2017 - 2021 ($ million)
Exhibits 19: Historic Market Size - End-user Segment 2017 - 2021 ($ million)
Exhibits 20: Historic Market Size - Product Segment 2017 - 2021 ($ million)
Exhibits 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
Exhibits 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
Exhibits 23: Five forces analysis - Comparison between 2022 and 2027
Exhibits 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
Exhibits 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
Exhibits 26: Threat of new entrants - Impact of key factors in 2022 and 2027
Exhibits 27: Threat of substitutes - Impact of key factors in 2022 and 2027
Exhibits 28: Threat of rivalry - Impact of key factors in 2022 and 2027
Exhibits 29: Chart on Market condition - Five forces 2022 and 2027
Exhibits 30: Chart on End-user - Market share 2022-2027 (%)
Exhibits 31: Data Table on End-user - Market share 2022-2027 (%)
Exhibits 32: Chart on Comparison by End-user
Exhibits 33: Data Table on Comparison by End-user
Exhibits 34: Chart on Hospitals - Market size and forecast 2022-2027 ($ million)
Exhibits 35: Data Table on Hospitals - Market size and forecast 2022-2027 ($ million)
Exhibits 36: Chart on Hospitals - Year-over-year growth 2022-2027 (%)
Exhibits 37: Data Table on Hospitals - Year-over-year growth 2022-2027 (%)
Exhibits 38: Chart on Clinics - Market size and forecast 2022-2027 ($ million)
Exhibits 39: Data Table on Clinics - Market size and forecast 2022-2027 ($ million)
Exhibits 40: Chart on Clinics - Year-over-year growth 2022-2027 (%)
Exhibits 41: Data Table on Clinics - Year-over-year growth 2022-2027 (%)
Exhibits 42: Chart on Others - Market size and forecast 2022-2027 ($ million)
Exhibits 43: Data Table on Others - Market size and forecast 2022-2027 ($ million)
Exhibits 44: Chart on Others - Year-over-year growth 2022-2027 (%)
Exhibits 45: Data Table on Others - Year-over-year growth 2022-2027 (%)
Exhibits 46: Market opportunity by End-user ($ million)
Exhibits 47: Data Table on Market opportunity by End-user ($ million)
Exhibits 48: Chart on Product - Market share 2022-2027 (%)
Exhibits 49: Data Table on Product - Market share 2022-2027 (%)
Exhibits 50: Chart on Comparison by Product
Exhibits 51: Data Table on Comparison by Product
Exhibits 52: Chart on Autolytic - Market size and forecast 2022-2027 ($ million)
Exhibits 53: Data Table on Autolytic - Market size and forecast 2022-2027 ($ million)
Exhibits 54: Chart on Autolytic - Year-over-year growth 2022-2027 (%)
Exhibits 55: Data Table on Autolytic - Year-over-year growth 2022-2027 (%)
Exhibits 56: Chart on Surgical - Market size and forecast 2022-2027 ($ million)
Exhibits 57: Data Table on Surgical - Market size and forecast 2022-2027 ($ million)
Exhibits 58: Chart on Surgical - Year-over-year growth 2022-2027 (%)
Exhibits 59: Data Table on Surgical - Year-over-year growth 2022-2027 (%)
Exhibits 60: Chart on Mechanical - Market size and forecast 2022-2027 ($ million)
Exhibits 61: Data Table on Mechanical - Market size and forecast 2022-2027 ($ million)
Exhibits 62: Chart on Mechanical - Year-over-year growth 2022-2027 (%)
Exhibits 63: Data Table on Mechanical - Year-over-year growth 2022-2027 (%)
Exhibits 64: Chart on Enzymatic - Market size and forecast 2022-2027 ($ million)
Exhibits 65: Data Table on Enzymatic - Market size and forecast 2022-2027 ($ million)
Exhibits 66: Chart on Enzymatic - Year-over-year growth 2022-2027 (%)
Exhibits 67: Data Table on Enzymatic - Year-over-year growth 2022-2027 (%)
Exhibits 68: Chart on Others - Market size and forecast 2022-2027 ($ million)
Exhibits 69: Data Table on Others - Market size and forecast 2022-2027 ($ million)
Exhibits 70: Chart on Others - Year-over-year growth 2022-2027 (%)
Exhibits 71: Data Table on Others - Year-over-year growth 2022-2027 (%)
Exhibits 72: Market opportunity by Product ($ million)
Exhibits 73: Data Table on Market opportunity by Product ($ million)
Exhibits 74: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 75: Impact of drivers and challenges in 2022 and 2027
Exhibits 76: Overview on Criticality of inputs and Factors of differentiation
Exhibits 77: Overview on factors of disruption
Exhibits 78: Impact of key risks on business
Exhibits 79: Vendors covered
Exhibits 80: Matrix on vendor position and classification
Exhibits 81: Arobella Medical LLC - Overview
Exhibits 82: Arobella Medical LLC - Product/Service
Exhibits 83: Arobella Medical LLC - Key offerings
Exhibits 84: B.Braun SE - Overview
Exhibits 85: B.Braun SE - Business segments
Exhibits 86: B.Braun SE - Key news
Exhibits 87: B.Braun SE - Key offerings
Exhibits 88: B.Braun SE - Segment focus
Exhibits 89: Bioventus LLC - Overview
Exhibits 90: Bioventus LLC - Business segments
Exhibits 91: Bioventus LLC - Key news
Exhibits 92: Bioventus LLC - Key offerings
Exhibits 93: Bioventus LLC - Segment focus
Exhibits 94: Coloplast AS - Overview
Exhibits 95: Coloplast AS - Business segments
Exhibits 96: Coloplast AS - Key news
Exhibits 97: Coloplast AS - Key offerings
Exhibits 98: Coloplast AS - Segment focus
Exhibits 99: ConvaTec Group Plc - Overview
Exhibits 100: ConvaTec Group Plc - Product/Service
Exhibits 101: ConvaTec Group Plc - Key news
Exhibits 102: ConvaTec Group Plc - Key offerings
Exhibits 103: Integra Lifesciences Corp. - Overview
Exhibits 104: Integra Lifesciences Corp. - Business segments
Exhibits 105: Integra Lifesciences Corp. - Key news
Exhibits 106: Integra Lifesciences Corp. - Key offerings
Exhibits 107: Integra Lifesciences Corp. - Segment focus
Exhibits 108: Labomar S.p.A - Overview
Exhibits 109: Labomar S.p.A - Product/Service
Exhibits 110: Labomar S.p.A - Key offerings
Exhibits 111: Lohmann and Rauscher GmbH and Co. KG - Overview
Exhibits 112: Lohmann and Rauscher GmbH and Co. KG - Product/Service
Exhibits 113: Lohmann and Rauscher GmbH and Co. KG - Key offerings
Exhibits 114: Medaxis AG - Overview
Exhibits 115: Medaxis AG - Product/Service
Exhibits 116: Medaxis AG - Key offerings
Exhibits 117: Mediwound Ltd. - Overview
Exhibits 118: Mediwound Ltd. - Product/Service
Exhibits 119: Mediwound Ltd. - Key offerings
Exhibits 120: Medline Industries LP - Overview
Exhibits 121: Medline Industries LP - Product/Service
Exhibits 122: Medline Industries LP - Key offerings
Exhibits 123: Molnlycke Health Care AB - Overview
Exhibits 124: Molnlycke Health Care AB - Product/Service
Exhibits 125: Molnlycke Health Care AB - Key offerings
Exhibits 126: Pulsecare Medical LLC - Overview
Exhibits 127: Pulsecare Medical LLC - Product/Service
Exhibits 128: Pulsecare Medical LLC - Key offerings
Exhibits 129: Smith and Nephew plc - Overview
Exhibits 130: Smith and Nephew plc - Business segments
Exhibits 131: Smith and Nephew plc - Key news
Exhibits 132: Smith and Nephew plc - Key offerings
Exhibits 133: Smith and Nephew plc - Segment focus
Exhibits 134: Zimmer Biomet Holdings Inc. - Overview
Exhibits 135: Zimmer Biomet Holdings Inc. - Business segments
Exhibits 136: Zimmer Biomet Holdings Inc. - Key news
Exhibits 137: Zimmer Biomet Holdings Inc. - Key offerings
Exhibits 138: Zimmer Biomet Holdings Inc. - Segment focus
Exhibits 139: Inclusions checklist
Exhibits 140: Exclusions checklist
Exhibits 141: Currency conversion rates for US$
Exhibits 142: Research methodology
Exhibits 143: Validation techniques employed for market sizing
Exhibits 144: Information sources
Exhibits 145: List of abbreviations

Executive Summary

The publisher recognizes the following companies as the key players in the global wound debridement market: Arobella Medical LLC, B.Braun SE, BioMonde Ltd., Bioventus LLC, Brightwake Ltd., Coloplast AS, ConvaTec Group Plc, DeRoyal Industries Inc., EZ Debride, Integra Lifesciences Corp., Labomar S.p.A, Lohmann and Rauscher GmbH and Co. KG, Medaxis AG, Mediwound Ltd., Medline Industries LP, Molnlycke Health Care AB, Pulsecare Medical LLC, RLS Global AB, Smith and Nephew plc, and Zimmer Biomet Holdings Inc..

Commenting on the report, an analyst from the research team said: 'The latest trend gaining momentum in the market is increasing use of telemedicine in wound debridement treatments.'

According to the report, one of the major drivers for this market is the technological advancements in wound debridement products.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Arobella Medical LLC
  • B.Braun SE
  • BioMonde Ltd.
  • Bioventus LLC
  • Brightwake Ltd.
  • Coloplast AS
  • ConvaTec Group Plc
  • DeRoyal Industries Inc.
  • EZ Debride
  • Integra Lifesciences Corp.
  • Labomar S.p.A
  • Lohmann and Rauscher GmbH and Co. KG
  • Medaxis AG
  • Mediwound Ltd.
  • Medline Industries LP
  • Molnlycke Health Care AB
  • Pulsecare Medical LLC
  • RLS Global AB
  • Smith and Nephew plc
  • Zimmer Biomet Holdings Inc.